[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Canada Nephrology and Urology Devices Market Outlook to 2025 - Renal Dialysis Equipment

April 2020 | 97 pages | ID: CDE41C981737EN
GlobalData

US$ 5,995.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Canada Nephrology and Urology Devices Market Outlook to 2025 - Renal Dialysis Equipment

SUMMARY

GlobalData’s “Canada Nephrology and Urology Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Canada Nephrology and Urology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Renal Dialysis Equipment.
The Canada Nephrology and Urology Devices Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2019 company share and distribution share data for Nephrology and Urology Devices Market.
  • Global corporate-level profiles of key companies operating within the Canada Nephrology and Urology Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
SCOPE

Canada Nephrology and Urology Devices is segmented as follows -
  • Renal Dialysis Equipment
REASONS TO BUY

The Canada Nephrology and Urology Devices Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 What Is This Report About?
2.2 Nephrology and Urology Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 NEPHROLOGY AND UROLOGY DEVICES MARKET, CANADA

3.1 Nephrology and Urology Devices Market, Canada, Revenue ($m), 2015-2025
3.2 Nephrology and Urology Devices Market, Canada, Revenue ($m), 2015-2025
3.3 Nephrology and Urology Devices Market, Canada, Volume (Units), 2015-2025
3.4 Nephrology and Urology Devices Market, Canada, Volume (Units), 2015-2025
3.5 Nephrology and Urology Devices Market, Canada, Company Share by Revenue ($m), 2019

4 RENAL DIALYSIS EQUIPMENT MARKET, CANADA

4.1 Renal Dialysis Equipment Market, Canada, Revenue Mix ($m), 2019
4.2 Renal Dialysis Equipment Market, Canada, Segment Contribution (%), 2019
4.3 Renal Dialysis Equipment Market, Canada, Revenue ($m), 2015-2025
  4.3.1 Dialysis Accessories Market, Canada, Revenue ($m), by Segment, 2015-2025
  4.3.2 Dialysis Machines Market, Canada, Revenue ($m), by Segment, 2015-2025
  4.3.3 Vascular Access Devices for Hemodialysis Market, Canada, Revenue ($m), by Segment, 2015-2025
4.4 Renal Dialysis Equipment Market, Canada, Volume (Units), 2015-2025
  4.4.1 Dialysis Accessories Market, Canada, Volume (Units) by Segment, 2015-2025
  4.4.2 Dialysis Machines Market, Canada, Volume (Units) by Segment, 2015-2025
  4.4.3 Vascular Access Devices for Hemodialysis Market, Canada, Volume (Units) by Segment, 2015-2025
4.5 Renal Dialysis Equipment Market, Canada, Average Price ($), 2015-2025
4.6 Renal Dialysis Equipment Market, Canada, Distribution Share by Revenue ($m), 2019
4.7 Renal Dialysis Equipment Market, Canada, Company Share by Revenue ($m), 2019

5 OVERVIEW OF KEY COMPANIES IN CANADA, NEPHROLOGY AND UROLOGY DEVICES MARKET

5.1 Fresenius Medical Care AG & Co KGaA
  5.1.1 Company Overview
5.2 Baxter International Inc
  5.2.1 Company Overview
5.3 Asahi Kasei Corp
  5.3.1 Company Overview
5.4 Nipro Corp
  5.4.1 Company Overview
5.5 B. Braun Melsungen AG
  5.5.1 Company Overview
5.6 CR Bard Inc
  5.6.1 Company Overview
5.7 Toray Medical Co Ltd
  5.7.1 Company Overview

6 NEPHROLOGY AND UROLOGY DEVICES MARKET PIPELINE PRODUCTS

7 FINANCIAL DEALS LANDSCAPE

7.1 Equity Offerings
  7.1.1 Spectral Medical Withdraws Public Offering of Common Shares
  7.1.2 Imagin Medical Raises USD1.5 Million in Private Placement of Units
  7.1.3 Kane Biotech Raises USD0.7 Million in Second Tranche of Private Placement of Units
  7.1.4 Kane Biotech Raises USD1.8 Million in First Tranche Private Placement of Units
  7.1.5 Aquarius Surgical Technologies Raises USD0.4 Million in First Tranche of Private Placement of Units
  7.1.6 Aquarius Surgical to Raise up to USD2.3 Million in Private Placement of Units
  7.1.7 Aquarius Surgical to Raise up to USD2 Million in Private Placement of Units
  7.1.8 Covalon Technologies Raises USD4.2 Million in Private Placement of Units

8 RECENT DEVELOPMENTS

8.1 Corporate Communications
  8.1.1 Feb 20, 2020: Kane Biotech welcomes renowned Canadian veterinarian, Dr. Jean Gauvin, as Chief Veterinary Officer
  8.1.2 Jan 06, 2020: CRH Medical appoints Tom Sanders as Vice President of Commercial Development
  8.1.3 Dec 16, 2019: Jean-Claude Dubacher named Chairman and Chief Executive Officer of B. Braun Medical
  8.1.4 Nov 19, 2019: Winterlight Labs raises Series A funds to develop AI vocal technology
  8.1.5 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership
  8.1.6 Jul 17, 2019: Spectral Medical announces new Chief Financial Officer
  8.1.7 May 01, 2019: Matinas BioPharma selected to present at the BioNJ Ninth Annual BioPartnering Conference
  8.1.8 Apr 17, 2019: Imagin Medical welcomes world-renowned Bladder Cancer expert Dr. Ashish M. Kamat to its Scientific Board of Advisors
  8.1.9 Apr 09, 2019: CRH Medical appoints Dr. Tushar Ramani as new CEO
8.2 Financial Announcements
  8.2.1 Mar 02, 2020: Covalon announces first quarter fiscal 2020 results
  8.2.2 Dec 24, 2019: Imagin Medical reports fiscal year end 2019 results
  8.2.3 Dec 13, 2019: Boehringer Ingelheim and Lilly provide update on Jardiance phase III exercise ability studies in chronic heart failure
  8.2.4 Nov 14, 2019: Kane Biotech announces third quarter 2019 financial results
  8.2.5 Nov 07, 2019: CRH Medical Corporation announces 2019 third quarter results
  8.2.6 Nov 05, 2019: Autolus Therapeutics receives FDA Orphan Drug Designation for AUTO1 for treatment of Acute Lymphoblastic Leukemia
  8.2.7 Aug 28, 2019: Covalon announces third quarter fiscal 2019 results
  8.2.8 Aug 27, 2019: Imagin Medical reports fiscal 2019 third quarter results
  8.2.9 Aug 21, 2019: Kane Biotech announces second quarter 2019 financial results
  8.2.10 Aug 15, 2019: Spectral announces second quarter results
  8.2.11 Aug 06, 2019: Kane Biotech awarded $3.8 million in non-dilutive government funding
  8.2.12 Jul 31, 2019: CRH Medical announces 2019 second quarter results
  8.2.13 Jun 25, 2019: Theralase brain cancer pre-clinical research accepted for publication
  8.2.14 Jun 11, 2019: Imagin Medical reports fiscal 2019 second quarter results
  8.2.15 May 28, 2019: Covalon announces second quarter fiscal 2019 results
  8.2.16 May 22, 2019: Kane Biotech Announces First Quarter 2019 Financial Results, Extension of Loan and Insider Funding
  8.2.17 May 09, 2019: Spectral announces first quarter results
  8.2.18 May 01, 2019: CRH Medical announces 2019 first quarter results
8.3 Government and Public Interest
  8.3.1 Oct 07, 2019: Digital kidney sheds light on link between hydration and acute injury
8.4 Legal And Regulatory
  8.4.1 Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker
8.5 Other Significant Developments
  8.5.1 Mar 05, 2020: ADDvise signs a new agreement with Laborie with a total order value of at least MSEK 50
  8.5.2 Feb 13, 2020: Laborie Medical Technologies closes Clinical Innovations acquisition
  8.5.3 Jan 27, 2020: Kane Biotech engages Independent Trading Group for market-making services
  8.5.4 Jan 23, 2020: Imagin Medical finishes 2019 strong and provides insight into 2020 & beyond
  8.5.5 Nov 26, 2019: Kane Biotech engages Kilmer Lucas for cross-border Investor Relations
  8.5.6 Nov 26, 2019: Aquarius Surgical Technologies reports increased sales in the first half of 2020
  8.5.7 Oct 23, 2019: CRH Medical announces new revolving credit facility
  8.5.8 Oct 17, 2019: Imagin Medical announces Social Media Campaign launch
  8.5.9 Aug 08, 2019: Spectral Medical provides corporate update
  8.5.10 Aug 01, 2019: Kane Biotech announces new funding granted from CanExport Program
  8.5.11 Jul 25, 2019: Covalon CEO provides corporate update
  8.5.12 Jun 10, 2019: Bactiguard enters Canada
  8.5.13 Apr 24, 2019: Kane Biotech announces new sales representation by SLA brands
  8.5.14 Apr 10, 2019: Canadian hospital Trillium Health Partners selects Sectra’s enterprise imaging solution
8.6 Product News
  8.6.1 May 02, 2019: Interface Biologics Poster Presentation at AUA 2019, Chicago, IL
8.7 Strategy And Business Planning
  8.7.1 Nov 07, 2019: Aquarius Surgical Technologies offers unique Equipment Financing through a partnership with Dext Capital

9 APPENDIX

9.1 Research Methodology
  9.1.1 Coverage
  9.1.2 Secondary Research
  9.1.3 Primary Research
  9.1.4 Market Modeling and Forecasting
  9.1.5 Company Share Analysis
  9.1.6 Distribution Share Analysis
  9.1.7 Benchmarking
9.2 GlobalData Consulting
9.3 Contact Us
9.4 Disclaimer

LIST OF TABLES

Table 1: Nephrology and Urology Devices Market, Canada, Revenue ($m), USD Constant, 2015-2025
Table 2: Nephrology and Urology Devices Market, Canada, Revenue ($m), USD Constant, 2015-2020
Table 3: Nephrology and Urology Devices Market, Canada, Revenue ($m), USD Constant, 2021-2025
Table 4: Nephrology and Urology Devices Market, Canada, Volume (Units), 2015-2025
Table 5: Nephrology and Urology Devices Market, Canada, Volume (Units), 2015-2020
Table 6: Nephrology and Urology Devices Market, Canada, Volume (Units), 2021-2025
Table 7: Nephrology and Urology Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2019
Table 8: Renal Dialysis Equipment Market, Canada, Segment Contribution (%), 2019
Table 9: Renal Dialysis Equipment Market, Canada, Revenue ($m), USD Constant, 2015-2020
Table 10: Renal Dialysis Equipment Market, Canada, Revenue ($m), USD Constant, 2021-2025
Table 11: Dialysis Accessories Market, Canada, Revenue ($m), USD Constant, 2015-2020
Table 12: Dialysis Accessories Market, Canada, Revenue ($m) USD Constant, 2021-2025
Table 13: Dialysis Machines Market, Canada, Revenue ($m), USD Constant, 2015-2020
Table 14: Dialysis Machines Market, Canada, Revenue ($m) USD Constant, 2021-2025
Table 15: Vascular Access Devices for Hemodialysis Market, Canada, Revenue ($m), USD Constant, 2015-2020
Table 16: Vascular Access Devices for Hemodialysis Market, Canada, Revenue ($m) USD Constant, 2021-2025
Table 17: Renal Dialysis Equipment Market, Canada, Volume (Units), 2015-2020
Table 18: Renal Dialysis Equipment Market, Canada, Volume (Units), 2021-2025
Table 19: Dialysis Accessories Market, Canada, Volume (Units), 2015-2020
Table 20: Dialysis Accessories Market, Canada, Volume (Units), 2021-2025
Table 21: Dialysis Machines Market, Canada, Volume (Units), 2015-2020
Table 22: Dialysis Machines Market, Canada, Volume (Units), 2021-2025
Table 23: Vascular Access Devices for Hemodialysis Market, Canada, Volume (Units), 2015-2020
Table 24: Vascular Access Devices for Hemodialysis Market, Canada, Volume (Units), 2021-2025
Table 25: Renal Dialysis Equipment Market, Canada, Average Price ($), 2015-2020
Table 26: Renal Dialysis Equipment Market, Canada, Average Price ($), 2021-2025
Table 27: Renal Dialysis Equipment Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2019
Table 28: Renal Dialysis Equipment Market, Canada, Company Share by Revenue ($m), USD Constant, 2019
Table 29: Nephrology and Urology Devices Market Pipeline Products
Table 30: Spectral Medical Withdraws Public Offering of Common Shares
Table 31: Imagin Medical Raises USD1.5 Million in Private Placement of Units
Table 32: Kane Biotech Raises USD0.7 Million in Second Tranche of Private Placement of Units
Table 33: Kane Biotech Raises USD1.8 Million in First Tranche Private Placement of Units
Table 34: Aquarius Surgical Technologies Raises USD0.4 Million in First Tranche of Private Placement of Units
Table 35: Aquarius Surgical to Raise up to USD2.3 Million in Private Placement of Units
Table 36: Aquarius Surgical to Raise up to USD2 Million in Private Placement of Units
Table 37: Covalon Technologies Raises USD4.2 Million in Private Placement of Units

LIST OF FIGURES

Figure 1: Nephrology and Urology Devices Market, Canada, Revenue ($m), USD Constant, 2015-2025
Figure 2: Nephrology and Urology Devices Market, Canada, Revenue ($m), USD Constant, 2015-2025
Figure 3: Nephrology and Urology Devices Market, Canada, Volume (Units), 2015-2025
Figure 4: Nephrology and Urology Devices Market, Canada, Volume (Units), 2015-2025
Figure 5: Nephrology and Urology Devices Market, Canada Company Share (%) 2019
Figure 6: Renal Dialysis Equipment Market, Canada, Revenue Mix ($m), 2019
Figure 7: Renal Dialysis Equipment Market, Canada, Segment Contribution (%), 2019
Figure 8: Renal Dialysis Equipment Market, Canada, Revenue ($m), USD Constant, 2015-2025
Figure 9: Dialysis Accessories Market, Canada, Revenue ($m), USD Constant, 2015-2025
Figure 10: Dialysis Machines Market, Canada, Revenue ($m), USD Constant, 2015-2025
Figure 11: Vascular Access Devices for Hemodialysis Market, Canada, Revenue ($m), USD Constant, 2015-2025
Figure 12: Renal Dialysis Equipment Market, Canada, Volume (Units), 2015-2025
Figure 13: Dialysis Accessories Market, Canada, Volume (Units), 2015-2025
Figure 14: Dialysis Machines Market, Canada, Volume (Units), 2015-2025
Figure 15: Vascular Access Devices for Hemodialysis Market, Canada, Volume (Units), 2015-2025
Figure 16: Renal Dialysis Equipment Market, Canada Company Share (%) 2019

COMPANIES MENTIONED

Fresenius Medical Care AG & Co KGaA
Baxter International Inc
Asahi Kasei Corp


More Publications